Comparison of Human Papillomavirus DNA Prevalence in Atypical Squamous Cells of Undetermined Significance Subcategories as Defined by the Original Bethesda 1991 and the New Bethesda 2001 Systems

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 5, 2004, Pages 527-532

  Pirog, Edyta C ^a   Erroll, Maria ^a   Harigopal, Malini ^a   Centeno, Barbara A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENOTYPE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 2342565877     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kurman R, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, NY: Springer-Verlag; 1994.
2. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
3. Crum CP, Genest DR, Krane JF, et al. Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am J Clin Pathol. 1999;112:384-390.
4. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477.
5. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153:1731-1739.
6. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999;37:2508-2517.
7. Renshaw AA, Granter SR. Appropriate follow-up interval for biopsy confirmation of squamous intraepithelial lesions diagnosed by cervical smear cytology. Am J Clin Pathol. 1997;108:275-279.
8. Grenko RT, Abendroth CS, Frauenhoffer RE, Ruggiero FM, Zaino RJ. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am J Clin Pathol. 2000;114:735-740.
9. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001;183:1554-1564.
10. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol. 1994;102:182-187.
11. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172:946-954.
12. Hughes SA, Sun D, Gibson C, et al. Managing atypical squamous cells of undetermined significance (ASCUS): human papillomavirus testing, ASCUS subtyping, or follow-up cytology? Am J Obstet Gynecol. 2002;186:396-403.
13. Hong IS, Marshalleck J, Williams RH, Gaiter TE, Mielzynska-Lohnas I, Kim K, Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples: a study of 608 cases. Acta Cytol. 2002;46:828-834.
14. Solomon D, Schiffman M, Tarone R, Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
15. Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol. 2001;14:147-151.
16. Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol. 2001;116:386-394.
17. Sherman ME, Tabbara SO, Scott DR, et al. "ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol. 1999;12:335-342.
18. Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis. 2003;30:581-587.
19. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev. 2003;12:1029-1037.
20. Sheils LA, Wilbur DC. Atypical squamous cells of undetermined significance: stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. Acta Cytol. 1997;41:1065-1072.
21. Voytek TM, Kannan V, Kline TS. Atypical parakeratosis: a marker of dysplasia? Diagn Cytopathol. 1996;15:288-291.
22. Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer. 1998;84:218-225.
23. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GI. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol. 1992;11:204-209.
24. Ettler HC, Joseph MG, Downing PA, Suskin NG, Wright VC. Atypical squamous cells of undetermined significance: a cytohistological study in a colposcopy clinic. Diagn Cytopathol. 1999;21:211-216.